For Irish Healthcare Professionals:
To ensure the medicine is used correctly and to avoid medication errors, the EMA has requested (as part of the Risk Management Plan) that Educational Materials be provided to all healthcare professionals who may potentially prescribe or dispense Jylamvo in Europe. The Educational Package fulfills that requirement and has further been reviewed and approved by the relevant national regulatory authority for distribution in that particular market.
For information specific for Ireland, please use following links:
The educational package comprises the following documents: